anthralin has been researched along with Disease Models, Animal in 11 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Anthralin is a widely used topical anti-psoriatic drug that may have an immunomodulating effect on alopecia areata (AA) as it does in psoriasis." | 7.72 | Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. ( Cao, L; Lui, H; Shapiro, J; Sundberg, JP; Tang, L, 2004) |
| "Anthralin is a widely used topical anti-psoriatic drug that may have an immunomodulating effect on alopecia areata (AA) as it does in psoriasis." | 3.72 | Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. ( Cao, L; Lui, H; Shapiro, J; Sundberg, JP; Tang, L, 2004) |
| "Alopecia areata is regarded as a tissue-restricted autoimmune disease of hair follicles in which follicular activity is arrested because of the continued activity of lymphocytic infiltrates." | 2.42 | Old wine in new bottles: reviving old therapies for alopecia areata using rodent models. ( Lui, H; Shapiro, J; Sundberg, JP; Tang, L, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Vilar, R | 1 |
| Lukowski, SW | 1 |
| Garieri, M | 1 |
| Di Sanza, C | 1 |
| Neerman-Arbez, M | 1 |
| Fish, RJ | 1 |
| Sathe, P | 1 |
| Saka, R | 1 |
| Kommineni, N | 1 |
| Raza, K | 2 |
| Khan, W | 1 |
| Katare, OP | 1 |
| Setia, A | 1 |
| Bhatia, A | 1 |
| Singh, B | 1 |
| Gábor, M | 1 |
| Tang, L | 2 |
| Sundberg, JP | 2 |
| Lui, H | 2 |
| Shapiro, J | 2 |
| Cao, L | 1 |
| Viluksela, M | 2 |
| Haasio, K | 1 |
| Männistö, PT | 1 |
| Hofbauer, M | 1 |
| Dowd, PM | 1 |
| Atkinson, J | 1 |
| Whitefield, M | 1 |
| Greaves, MW | 1 |
| Yuspa, SH | 1 |
3 reviews available for anthralin and Disease Models, Animal
| Article | Year |
|---|---|
Models of acute inflammation in the ear.
Topics: Alkynes; Animals; Anthralin; Arachidonic Acid; Cantharidin; Capsaicin; Carrageenan; Croton Oil; Derm | 2003 |
Old wine in new bottles: reviving old therapies for alopecia areata using rodent models.
Topics: Alopecia Areata; Animals; Anthralin; Disease Models, Animal; Mechlorethamine; Rodentia | 2003 |
Cutaneous chemical carcinogenesis.
Topics: Animals; Anthralin; Carcinogens; Cell Transformation, Neoplastic; Disease Models, Animal; DNA; Enzym | 1986 |
8 other studies available for anthralin and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Chemical Modulators of Fibrinogen Production and Their Impact on Venous Thrombosis.
Topics: Animals; Animals, Genetically Modified; Anthralin; Blood Coagulation; Disease Models, Animal; Fibrin | 2021 |
Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Topics: Administration, Cutaneous; Animals; Anthralin; Dermatologic Agents; Disease Models, Animal; Drug Car | 2019 |
Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes.
Topics: Animals; Anthralin; Dermatologic Agents; Disease Models, Animal; Emulsions; Humans; Mice; Nanostruct | 2013 |
Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin.
Topics: Administration, Topical; Alopecia Areata; Animals; Anthralin; Anti-Inflammatory Agents; Cytokines; D | 2004 |
Characteristics and modulation of dithranol (anthralin)-induced skin irritation in the mouse ear model.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Anthralin; Anti-Inflammatory Agents, Non- | 1991 |
Studies on the contact sensitizing activity of dithranol (anthralin) and 10-butyryl dithranol (butantrone).
Topics: Animals; Anthralin; Dermatitis, Contact; Disease Models, Animal; Dose-Response Relationship, Immunol | 1990 |
Evaluation of a therapeutic concentration of dithranol in the mouse-tail test.
Topics: Animals; Anthralin; Disease Models, Animal; Female; Male; Mice; Mice, Hairless; Psoriasis; Random Al | 1988 |